Efficient in vivo vascularization of tissue-engineering scaffolds

Journal of Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 4, 2011, Pages

  Hegen, Anja ^a   Blois, Anna ^a   Tiron, Crina E ^a   Hellesøy, Monica ^a   Micklem, David R ^a   Nör, Jacques E ^c   Akslen, Lars A ^a,b   Lorens, James B ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Angiogenesis; Endothelial; Microcirculation; Multiphoton; Mural cell; Scaffold

Indexed keywords

BIOLOGICAL MEMBRANES; BUILDINGS; CELL ENGINEERING; CYTOLOGY; ENDOTHELIAL CELLS; FLUORESCENCE; FLUORESCENCE MICROSCOPY; LACTIC ACID; PROTEINS; SCAFFOLDS (BIOLOGY); SELF ASSEMBLY;

ANGIOGENESIS; ENDOTHELIAL; IN-VIVO; MICROVASCULAR; MICROVESSELS; MULTIPHOTONS; MURAL CELL; TISSUES ENGINEERINGS; VASCULARIZATION; VIVO TISSUE ENGINEERING;

BLOOD VESSELS;

MATRIGEL; POLYLACTIC ACID; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY SMOOTH MUSCLE CELL; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

EID: 79952757061     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.336     Document Type: Article

References (50)

1. Adams RH, Alitalo K. 2007; Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8: 464-478.
2. Alajati A, Laib AM, Weber H, et al. 2008; Spheroid-based engineering of a human vasculature in mice. Nat Methods 5: 439-445.
3. Au P, Tam J, Fukumura D, et al. 2008; Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 111: 4551-4558.
4. Beck L Jr, D'Amore PA. 1997; Vascular development: cellular and molecular regulation. FASEB J 11: 365-373.
5. Benjamin LE, Hemo I, Keshet E. 1998; A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591-1598.
6. Black AF, Berthod F, L'Heureux N, et al. 1998; In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J 12: 1331-1340.
7. Black AF, Hudon V, Damour O, et al. 1999; A novel approach for studying angiogenesis: a human skin equivalent with a capillary-like network. Cell Biol Toxicol 15: 81-90.
8. Carmeliet P. 2003; Angiogenesis in health and disease. Nat Med 9: 653-660.
9. Darland DC, D'Amore PA. 1999; Blood vessel maturation: vascular development comes of age. J Clin Invest 103: 157-158.
10. Darland DC, D'Amore PA. 2001; Cell-cell interactions in vascular development. Curr Top Dev Biol 52: 107-149.
11. Davis GE, Senger DR. 2005; Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 97: 1093-1107.
12. Dougherty RP, Kunzelmann K-H. 2007; Local Thickness plugin; computing local thickness of 3D structures with ImageJ. Microscopy and Microanalysis 2007 Meeting, 5-9 August 2007, Fort Lauderdale, FL: .
13. Evensen L, Micklem DR, Blois A, et al. 2009; Mural cell associated VEGF is required for organotypic vessel formation. PLoS One 4: e5798.
14. Evensen L, Micklem DR, Link W, et al. 2010; A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery. Cytometry A 77: 41-51.
15. Freeman JW, Woods MD, Laurencin CT. 2007; Tissue engineering of the anterior cruciate ligament using a braid-twist scaffold design. J Biomech 40: 2029-2036.
16. Gaengel K, Genove G, Armulik A, et al. 2009; Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29: 630-638.
17. Garlanda C, Dejana E. 1997; Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 17: 1193-1202.
18. Gerhardt H, Betsholtz C. 2003; Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314: 15-23.
19. Gjerdrum C, Tiron C, Hoiby T, et al. 2010; Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci USA 107: 1124-1129.
20. Gray H, Bannister LH, Dyson M, et al. 2004; Gray's Anatomy: the Anatomical Basis of Medicine and Surgery. Churchill-Livingstone: Edinburgh.
21. Greenberg JI, Shields DJ, Barillas SG, et al. 2008; A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456: 809-813.
22. Hall AP. 2006; Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy. Toxicol Pathol 34: 763-775.
23. Hellstrom M, Gerhardt H, Kalen M, et al. 2001; Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol 153: 543-553.
24. Holland SJ, Powell MJ, Franci C, et al. 2005; Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res 65: 9294-9303.
25. Jain RK. 2003; Molecular regulation of vessel maturation. Nat Med 9: 685-693.
26. Jenkins GW, Kemnitz CP, Tortora GJ. 2007; Anatomy and Physiology. Wiley: New York.
27. Kaully T, Kaufman-Francis K, Lesman A, et al. 2009; Vascularization-the conduit to viable engineered tissues. Tissue Eng Part B Rev 15: 159-169.
28. Koike N, Fukumura D, Gralla O, et al. 2004; Tissue engineering: creation of long-lasting blood vessels. Nature 428: 138-139.
29. Korff T, Kimmina S, Martiny-Baron G, et al. 2001; Blood vessel maturation in a three-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 15: 447-457.
30. Kutcher ME, Herman IM. 2009; The pericyte: cellular regulator of microvascular blood flow. Microvasc Res 77: 235-246.
31. Lazarous DF, Shou M, Scheinowitz M, et al. 1996; Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94: 1074-1082.
32. McDonald DM, Choyke PL. 2003; Imaging of angiogenesis: from microscope to clinic. Nat Med 9: 713-725.
33. Melero-Martin JM, De Obaldia ME, Kang SY, et al. 2008; Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103: 194-202.
34. Melero-Martin JM, Khan ZA, Picard A, et al. 2007; In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109: 4761-4768.
35. Muschler GF, Nakamoto C, Griffith LG. 2004; Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86A: 1541-1558.
36. Nguyen LL, D'Amore PA. 2001; Cellular interactions in vascular growth and differentiation. Int Rev Cytol 204: 1-48.
37. Nor JE, Peters MC, Christensen JB, et al. 2001; Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 81: 453-463.
38. Ohnuma K, Yomo T, Asashima M, et al. 2006; Sorting of cells of the same size, shape, and cell cycle stage for a single cell level assay without staining. BMC Cell Biol 7: 25.
39. Ozawa CR, Banfi A, Glazer NL, et al. 2004; Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113: 516-527.
40. Patterson TE, Kumagai K, Griffith L, et al. 2008; Cellular strategies for enhancement of fracture repair. J Bone Joint Surg Am 90(suppl 1): 111-119.
41. Rasband WS. 1997-2008; ImageJ. In Health. USNIO: Bethesda, MD, USA.
42. Sanz L, Santos-Valle P, Alonso-Camino V, et al. 2008; Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels. Microvasc Res 75: 308-314.
43. Schechner JS, Nath AK, Zheng L, et al. 2000; In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci USA 97: 9191-9196.
44. Shepherd BR, Jay SM, Saltzman WM, et al. 2009; Human aortic smooth muscle cells promote arteriole formation by coengrafted endothelial cells. Tissue Eng A 15: 165-173.
45. Silverthorn DU, William CO, Garrison CW, et al. 2004; Human Physiology-An Integrated Approach. Daryl Fox: San Francisco, CA.
46. Swift S, Lorens J, Achacoso P, et al. 1999; Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol 10.17.14-10.17.29.
47. Von Degenfeld G, Banfi A, Springer ML, et al. 2006; Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. FASEB J 20: 2657-2659.
48. Wenger A, Kowalewski N, Stahl A, et al. 2005; Development and characterization of a spheroidal coculture model of endothelial cells and fibroblasts for improving angiogenesis in tissue engineering. Cells Tissues Organs 181: 80-88.
49. Wilkinson-Berka JL, Babic S, De Gooyer T, et al. 2004; Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. Am J Pathol 164: 1263-1273.
50. Yun Chen AFTM, Min W, Jiashen L, et al. 2006; PLLA scaffolds with biomimetic apatite coating and biomimetic apatite/collagen composite coating to enhance osteoblast-like cells attachment and activity. Surf Coat Tech 201: 575-580.